Annsley Merelle Ward
reported on a significant UPC Court of Appeal decision that reversed a first instance ruling, granting a preliminary injunction to
Boehringer Ingelheim against
Zentiva. The judgment clarifies the test for "imminent infringement", suggesting that completing national pricing and reimbursement procedures for a generic drug can be enough to "set the stage" for infringement.
Jocelyn Bosse
provided an overview of a recently published expert report on the patent governance of agricultural gene editing. The report details discussions among experts on regulatory developments in the EU and UK, the role of the precautionary principle in patent law, and the challenges of using licensing to ensure access to innovation.
Annsley Merelle Ward
presented a comprehensive review of recent Belgian patent litigation, courtesy of the team at
Stibbe. The analysis covers key decisions on the intersection of IP and competition law, the first European judgment on the merits of the SPC manufacturing waiver, and the admissibility of evidence obtained via a saisie order that is later annulled.
Rose Hughes
walked us through EPO Board of Appeal decision
T 2387/22, which addresses the clarity of functional claim language in use claims. The Board found that when an invention is based on a relative improvement of a known effect, that improvement must be defined in objectively verifiable terms to ensure legal certainty.